Come up with a name for your new list and we'll add to it:
Cytune Pharma was acquired by
PPF Group on August 30, 2018.
Cytune Pharma is developing a portfolio of immunotherapeutic agents to treat primarily cancer. Cytune's compound, CYP 0150, is a human interleukin-15 linked to its effector.…